http://www.inhibitortargets.com/index.php/2017/10/31/cellular-dependency-fgfr1-sensitivity-fgfr-inhibitors/ 2022-01-14T05:07:25+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/30/acute-experiments-powerful-strategy-find-inhibitor-motifs/ 2022-01-14T05:07:25+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/27/demonstrated-experimentally-hypercoagulant-state-developed/ 2022-01-14T05:07:25+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/26/basic-group-orcinol-core-potent-derivatives/ 2022-01-14T05:07:25+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/25/antithrombin-activity-insufficient-compounds-actual-anticoagulants/ 2022-01-14T05:07:25+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/24/focused-variations-basic-fragments-p1-position-search/ 2022-01-14T05:07:25+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/22/nature-p2-inhibitor-position-easy-polarizable-p1-fragments-abundance/ 2022-01-14T05:07:25+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/20/inhibitors-blood-plasma-thrombin-works/ 2022-01-14T05:07:32+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/19/kinetics-thrombin-inhibition-determined-hydrolysis/ 2022-01-14T05:07:32+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/17/protocol-compare-native-ligand-respective-pdb-protein-ligand/ 2022-01-14T05:07:33+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/17/perform-docking-program-ligands-protein-preprocessing-protein/ 2022-01-14T05:07:33+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/15/structures-thrombin-complexes-diverse-set-experimental-inhibitors/ 2022-01-14T05:07:33+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/13/permanent-activation-coagulation-eventually-exhausting-pool-coagulation-inhibitors/ 2022-01-14T05:07:33+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/11/bound-aph-enzymes-aminoethyl-amide-adopts-extended-conformation/ 2022-01-14T05:07:33+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/10/remainder-cki-7-inhibitor-aminoethylsulfonamide-adopts-conformations/ 2022-01-14T05:07:33+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/09/implies-inhibitors-enzymes-exploited-development-drug-adjuvant/ 2022-01-14T05:07:33+00:00 daily 0.9 http://www.inhibitortargets.com/index.php/2017/10/09/crystal-structure-pbp2a-apo-form-complexed-b-lactams-shown-methicillin/ 2022-01-14T05:07:33+00:00 daily 0.9